A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

Recruiting Observational Study
Drug Abuse, Intravenous Substance Dependence Needle Injury Soft Tissue Injuries Foreign Bodies
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Tampere University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous sclerosis, tissue necrosis, and drug needle fragment retentions. Drug needle fragments in subcutaneous tissue may cause local symptoms (usually pain and infections), but they have also been identified as causing emboli to organs. The literature…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * History of intravenous drug use * Current treatment of the drug abuse problem at a local low-threshold drug abuse service unit or primary health care centre. * Adherence to fill in the questionnaire * Participation to X-ray imaging of injection sites Exclusion Criteria: * No…
Contacts

Otso Arponen, Associate Professor, MD

+358 50 410 6170

otso.arponen@tuni.fi

CONTACT